{"id":75781,"date":"2026-08-21T14:46:55","date_gmt":"2026-08-21T06:46:55","guid":{"rendered":"https:\/\/flcube.com\/?p=75781"},"modified":"2026-08-21T14:46:57","modified_gmt":"2026-08-21T06:46:57","slug":"metis-and-westvac-biopharma-forge-ai-partnership-to-develop-personalized-mrna-cancer-vaccines","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=75781","title":{"rendered":"METiS and WestVac Biopharma Forge AI Partnership to Develop Personalized mRNA Cancer Vaccines"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>METiS TechBio<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/7666:HKG\">HKG: 7666<\/a>) and <strong>WestVac Biopharma<\/strong>, an innovative vaccine and immunotherapy company led by Academician <strong>Yuquan Wei<\/strong> of the Chinese Academy of Sciences, officially signed a <strong>strategic cooperation framework agreement<\/strong> to jointly accelerate the development of next\u2011generation <strong>personalized mRNA cancer vaccines<\/strong> driven by <strong>AI<\/strong> \u2014 combining METiS&#8217; proprietary <strong>NanoForge<\/strong> AI nano\u2011delivery platform with WestVac&#8217;s vaccine R&amp;D and industrialization capabilities.<\/p>\n\n\n\n<h2 id=\"h-partnership-milestone\" class=\"wp-block-heading\">Partnership Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Partners<\/strong><\/td><td>METiS TechBio (HKG: 7666) \u00d7 WestVac Biopharma<\/td><\/tr><tr><td><strong>Agreement<\/strong><\/td><td>Strategic cooperation framework agreement<\/td><\/tr><tr><td><strong>Signing Date<\/strong><\/td><td>21 Aug 2026<\/td><\/tr><tr><td><strong>Focus<\/strong><\/td><td>AI\u2011driven personalized mRNA cancer vaccines<\/td><\/tr><tr><td><strong>Key Platforms<\/strong><\/td><td>METiS NanoForge (AI nano\u2011delivery) + WestVac vaccine R&amp;D and industrialization platform<\/td><\/tr><tr><td><strong>Leadership Context<\/strong><\/td><td>WestVac led by Academician Yuquan Wei, Chinese Academy of Sciences<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-technology-synergy-ai-meets-vaccine-industrialization\" class=\"wp-block-heading\">Technology Synergy \u2013 AI Meets Vaccine Industrialization<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Under the agreement, the two companies will combine <strong>METiS&#8217; end\u2011to\u2011end Biological AI capabilities<\/strong> from NanoForge with <strong>WestVac&#8217;s<\/strong> vaccine R&amp;D and industrialization platform. Driven by AI, both sides will jointly explore applications in AI\u2011assisted personalized antigen screening, design, and delivery \u2014 accelerating the innovation and clinical translation of next\u2011generation personalized mRNA cancer vaccines.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Partner<\/th><th>Contribution<\/th><\/tr><\/thead><tbody><tr><td><strong>METiS TechBio<\/strong><\/td><td>Core NanoForge platform technologies, including <strong>AiLNP<\/strong> and <strong>AiRNA<\/strong><\/td><\/tr><tr><td><strong>WestVac Biopharma<\/strong><\/td><td>Industrial expertise in antigen design, vaccine manufacturing processes, and clinical development<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-strategic-rationale\" class=\"wp-block-heading\">Strategic Rationale<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>AI\u2011Accelerated Design:<\/strong> NanoForge&#8217;s AiLNP and AiRNA modules apply AI across the delivery and RNA design stack, aiming to compress timelines and improve precision in personalized vaccine construction<\/li>\n\n\n\n<li><strong>Industrialization Edge:<\/strong> WestVac contributes proven capabilities in translating vaccine science into manufactured, clinically developed products \u2014 a critical bridge from algorithm to clinic<\/li>\n\n\n\n<li><strong>Personalization at Scale:<\/strong> The partnership targets the core challenge of personalized oncology: rapidly tailoring mRNA cancer vaccines to individual tumor antigen profiles with reproducible manufacturing<\/li>\n\n\n\n<li><strong>Clinical Translation Focus:<\/strong> Both parties emphasize moving beyond discovery toward clinical implementation, positioning the collaboration to pursue regulatory\u2011grade development<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Hot Convergence:<\/strong> The deal reflects the accelerating convergence of <strong>AI<\/strong> and biotech, as investors and pharma increasingly back AI\u2011native platforms that promise faster, cheaper drug design cycles<\/li>\n\n\n\n<li><strong>Personalized Vaccine Race:<\/strong> Personalized mRNA cancer vaccines have emerged as one of oncology&#8217;s most competitive frontiers, with global players pursuing neoantigen\u2011based approaches and combination strategies with immunotherapy<\/li>\n\n\n\n<li><strong>Platform Validation:<\/strong> For <strong>METiS<\/strong>, the partnership validates NanoForge&#8217;s commercial relevance and extends its Biological AI stack into vaccine applications with a seasoned industrialization partner<\/li>\n\n\n\n<li><strong>China Biotech Signal:<\/strong> The collaboration underscores China&#8217;s growing strength in AI\u2011driven biotech, pairing listed techbio (HKG: 7666) with academician\u2011led vaccine innovation<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the METiS\u2011WestVac strategic cooperation, technology development, and clinical translation of personalized mRNA cancer vaccines. Actual results may differ due to risks including scientific feasibility, regulatory pathways, competitive dynamics, and commercialization timelines.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>METiS TechBio (HKG: 7666) and WestVac Biopharma, an innovative vaccine and immunotherapy company led by&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10,93],"tags":[99,16,19,4829,4828,63,12,2817],"class_list":["post-75781","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","category-digital","tag-ai","tag-cancer","tag-cro-cmo-cdmo","tag-hkg-7666","tag-metis-techbio","tag-mrna","tag-vaccine","tag-westvac-biopharma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>METiS and WestVac Biopharma Forge AI Partnership to Develop Personalized mRNA Cancer Vaccines - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"METiS TechBio (HKG: 7666) and WestVac Biopharma, an innovative vaccine and immunotherapy company led by Academician Yuquan Wei of the Chinese Academy of Sciences, officially signed a strategic cooperation framework agreement to jointly accelerate the development of next\u2011generation personalized mRNA cancer vaccines driven by AI \u2014 combining METiS&#039; proprietary NanoForge AI nano\u2011delivery platform with WestVac&#039;s vaccine R&amp;D and industrialization capabilities.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=75781\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"METiS and WestVac Biopharma Forge AI Partnership to Develop Personalized mRNA Cancer Vaccines\" \/>\n<meta property=\"og:description\" content=\"METiS TechBio (HKG: 7666) and WestVac Biopharma, an innovative vaccine and immunotherapy company led by Academician Yuquan Wei of the Chinese Academy of Sciences, officially signed a strategic cooperation framework agreement to jointly accelerate the development of next\u2011generation personalized mRNA cancer vaccines driven by AI \u2014 combining METiS&#039; proprietary NanoForge AI nano\u2011delivery platform with WestVac&#039;s vaccine R&amp;D and industrialization capabilities.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=75781\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-21T06:46:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-21T06:46:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75781#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75781\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"METiS and WestVac Biopharma Forge AI Partnership to Develop Personalized mRNA Cancer Vaccines\",\"datePublished\":\"2026-08-21T06:46:55+00:00\",\"dateModified\":\"2026-08-21T06:46:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75781\"},\"wordCount\":470,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"AI\",\"Cancer\",\"CRO \\\/ CMO \\\/ CDMO\",\"HKG: 7666\",\"METiS TechBio\",\"mRNA\",\"Vaccine\",\"WestVac Biopharma\"],\"articleSection\":[\"Company\",\"Deals\",\"Digital\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=75781#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75781\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=75781\",\"name\":\"METiS and WestVac Biopharma Forge AI Partnership to Develop Personalized mRNA Cancer Vaccines - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-08-21T06:46:55+00:00\",\"dateModified\":\"2026-08-21T06:46:57+00:00\",\"description\":\"METiS TechBio (HKG: 7666) and WestVac Biopharma, an innovative vaccine and immunotherapy company led by Academician Yuquan Wei of the Chinese Academy of Sciences, officially signed a strategic cooperation framework agreement to jointly accelerate the development of next\u2011generation personalized mRNA cancer vaccines driven by AI \u2014 combining METiS' proprietary NanoForge AI nano\u2011delivery platform with WestVac's vaccine R&D and industrialization capabilities.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75781#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=75781\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=75781#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"METiS and WestVac Biopharma Forge AI Partnership to Develop Personalized mRNA Cancer Vaccines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"METiS and WestVac Biopharma Forge AI Partnership to Develop Personalized mRNA Cancer Vaccines - Insight, China&#039;s Pharmaceutical Industry","description":"METiS TechBio (HKG: 7666) and WestVac Biopharma, an innovative vaccine and immunotherapy company led by Academician Yuquan Wei of the Chinese Academy of Sciences, officially signed a strategic cooperation framework agreement to jointly accelerate the development of next\u2011generation personalized mRNA cancer vaccines driven by AI \u2014 combining METiS' proprietary NanoForge AI nano\u2011delivery platform with WestVac's vaccine R&D and industrialization capabilities.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=75781","og_locale":"en_US","og_type":"article","og_title":"METiS and WestVac Biopharma Forge AI Partnership to Develop Personalized mRNA Cancer Vaccines","og_description":"METiS TechBio (HKG: 7666) and WestVac Biopharma, an innovative vaccine and immunotherapy company led by Academician Yuquan Wei of the Chinese Academy of Sciences, officially signed a strategic cooperation framework agreement to jointly accelerate the development of next\u2011generation personalized mRNA cancer vaccines driven by AI \u2014 combining METiS' proprietary NanoForge AI nano\u2011delivery platform with WestVac's vaccine R&D and industrialization capabilities.","og_url":"https:\/\/flcube.com\/?p=75781","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-21T06:46:55+00:00","article_modified_time":"2026-08-21T06:46:57+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=75781#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=75781"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"METiS and WestVac Biopharma Forge AI Partnership to Develop Personalized mRNA Cancer Vaccines","datePublished":"2026-08-21T06:46:55+00:00","dateModified":"2026-08-21T06:46:57+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=75781"},"wordCount":470,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["AI","Cancer","CRO \/ CMO \/ CDMO","HKG: 7666","METiS TechBio","mRNA","Vaccine","WestVac Biopharma"],"articleSection":["Company","Deals","Digital"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=75781#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=75781","url":"https:\/\/flcube.com\/?p=75781","name":"METiS and WestVac Biopharma Forge AI Partnership to Develop Personalized mRNA Cancer Vaccines - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-08-21T06:46:55+00:00","dateModified":"2026-08-21T06:46:57+00:00","description":"METiS TechBio (HKG: 7666) and WestVac Biopharma, an innovative vaccine and immunotherapy company led by Academician Yuquan Wei of the Chinese Academy of Sciences, officially signed a strategic cooperation framework agreement to jointly accelerate the development of next\u2011generation personalized mRNA cancer vaccines driven by AI \u2014 combining METiS' proprietary NanoForge AI nano\u2011delivery platform with WestVac's vaccine R&D and industrialization capabilities.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=75781#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=75781"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=75781#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"METiS and WestVac Biopharma Forge AI Partnership to Develop Personalized mRNA Cancer Vaccines"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75781","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=75781"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75781\/revisions"}],"predecessor-version":[{"id":75820,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/75781\/revisions\/75820"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=75781"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=75781"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=75781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}